RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1002%2Fhep.23276

https://w3id.org/ripe/ripe-kg/work/10.1002%2Fhep.23276
SubjectPredicateObject
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis prism:doi 10.1002/hep.23276
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis dcterms:title Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis rdf:type node1
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis rdf:type rdfs:Resource
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis rdf:type owl:Thing
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis rdf:type prov:Entity
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis rdf:type ripe:WorkWork
ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis owl:sameAs https://semopenalex.org/work/W1997425045
ripekg:work/10.1002%2Fptr.6406Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial http://purl.org/spar/cito/cites ripekg:work/10.1002%2Fhep.23276Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis